|
COMMERCE BUSINESS DAILY ISSUE OF DECEMBER 31,1997 PSA#2002National Cancer Institute, Research Contracts Branch, Cancer Etiology
Contracts Section, Executive Plaza South, Rm. 620, 6120 Executive
Blvd., MSC 7224, Bethesda, MD 20892-7224 A -- THE GUANCASTE PROJECT: A POPULATION-BASED NATURAL HISTORY STUDY
OF HPV INFECTION AND CERVICAL NEOPLASIA SOL N01-CP-81023-50 DUE 012898
POC Karen L. McFarlane, Contracting Officer, (301) 435-3782 E-MAIL:
Karen L. McFarlane, KM63K@NIH.GOV. The Environmental Epidemiology
Branch (EEB) of the Division of Cancer Epidemiology and Genetics (DCEG)
of the National Cancer Institute (NCI) intends to negotiate with
FUCODOCSA, Costa Rican Bureau of Social Security, Costa Rica, for a
three year follow-on contract for completion of the follow-up of the
random sample of approximately 10,000 women 18 -- 69 years
participating in a natural history study of cervical neoplasia in Costa
Rican women begun under contracts N01-CP-33061, N01-CP-40542, and
N01-CP-50535. Authority: 41 USC 253(c)(1), as set forth in FAR 6.302-1.
Numbered Note 22 applies as follows: The proposed contract action is
for supplies or services for which the Government intends to solicit
and negotiate with only one source under the authority of FAR 6.302.
Interested persons may identify their interest and capability to
respond to the requirement or submit proposals. This notice of intent
is not a request for competitive proposals. However, all proposals
received within forty-five days(thirty days if award is issued under an
existing basic ordering agreement) after date of publication of this
synopsis will be considered by the Government. A determination by the
Government not to compete with this proposed contract based upon
responses to this notice is solely within the discretion of the
Government. Information received will normally be considered solely for
the purpose of determining whether to conduct a competitive
procurement. No collect calls will be accepted. (0363) Loren Data Corp. http://www.ld.com (SYN# 0001 19971231\A-0001.SOL)
A - Research and Development Index Page
|
|